ArticleBMC women's health2025
Assessment of risk factors for high-grade cervical or endometrial lesions to triage women with AGC-FN: a retrospective study.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtypical glandular cells, favor neoplastic (AGC-FN) identified in Papanicolaou (Pap) smears may be indicative of pre-malignant and malignant cervical and endometrial lesions. However, an effective strategy for triaging patients with AGC-FN remains elusive. This study aimed to analyze the relationship between AGC-FN and high-grade lesions, as well as identify specific risk factors which can optimize the currently strategy in women with AGC-FN.
methodsThis retrospective utilized data from the China's Fujian Cervical Pilot Project (FCPP). A total of 211 women diagnosed with AGC-FN according to the Bethesda 2014 classification system underwent follow-up through colposcopy, biopsy, and endometrial curettage between January 2013 and July 2021. The association between high-grade lesions and clinicopathologic features were analyzed using independent sample nonparametric tests and binary logistic regression. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of different triage strategie were evaluated.
resultsThere were 43.60% (92/211) and 27.96% (59/211) AGC-FN women diagnosed as ≥ endometrial precancerous lesions (≥ EPL) and CIN2 + , respectively. In women with ≥ EPL, the top 3 risk factors were higher HE4, higher CA125 and older age (adjusted odds ratio [OR
conclusionCA125 and HR-HPV infection emerged as significant risk factors for triaging women with AGC-FN and HPV-16 and -18, HPV-58 and -59 infections should not to be overlooked. A novel triage strategy combining CA125, CA199, HE4 and HR-HPV reduced the referral rates of biopsy and curettage without altering the original sensitivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.